Standigm
Standigm is an AI-driven drug discovery company that offers state-of-the-art AI SaaS & API solutions. They provide end-to-end solutions for drug discovery, from novel target identification to lead optimization and preclinical candidate material derivation. Their proprietary AI platforms, including Standigm ASK™ for target discovery, Standigm BEST™ for lead design, and Standigm Insight™ for drug repurposing, aim to industrialize drug discovery. They have demonstrated a significant reduction in lead optimization time, from an average of 4.5 years to 1.5 years, by utilizing their platform.
Standigm
Standigm is an AI-driven drug discovery company that offers state-of-the-art AI SaaS & API solutions. They provide end-to-end solutions for drug discovery, from novel target identification to lead optimization and preclinical candidate material derivation. Their proprietary AI platforms, including Standigm ASK™ for target discovery, Standigm BEST™ for lead design, and Standigm Insight™ for drug repurposing, aim to industrialize drug discovery. They have demonstrated a significant reduction in lead optimization time, from an average of 4.5 years to 1.5 years, by utilizing their platform.